Delivery Order SPE2DE21D7010-SPE2D626F094G
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, was awarded a fixed-price delivery order valued at $8,427.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 16, 2025. The contract, designated as the SIMPLIFY delivery order, includes economic price adjustment provisions and is scheduled for completion by August 12, 2025. This award was made without set-aside designation, indicating Nuvasive competed...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, received a $16,960 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025, with completion targeted for September 22, 2025. The contract, designated as SIMPLIFY, represents a non-competitive procurement with no set-aside designation, reflecting Nuvasive's established capability to compete successfully in open market...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and technologies, was awarded a delivery order valued at $8,533.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 14, 2025. This fixed-price delivery order with economic price adjustment mechanism does not utilize any set-aside designation, indicating the contract was awarded through open market competition. The contract is scheduled for completion by August 15, 2025, and...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- Nuvasive, Inc. has been awarded a $37,861.56 delivery order by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency supporting Department of Defense and Veterans Affairs healthcare operations. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 18, 2025, and involves the delivery of specialized spinal medical technologies and surgical equipment to support military and veteran healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $1,681.90 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 24, 2025. This fixed-price contract with economic price adjustment mechanisms is set to be completed by July 25, 2025. The award represents an open market procurement with no set-aside designation, consistent with Nuvasive's established competitive success in federal healthcare...
- Nuvasive, Inc. was awarded a $9,368 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 3, 2025. This fixed-price contract with economic price adjustment mechanisms represents a non-competitive procurement with no set-aside designation. Nuvasive, a San Diego-based medical device company specializing in spinal surgery products and services, will deliver advanced spinal medical technologies, implants, and...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. The contract, designated as "SMALL INTERLOCK II," represents a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 22, 2025. The award was made without any set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, received a delivery order award valued at $8,533 from the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 22, 2025, and carries no set-aside designation, indicating competitive open-market procurement. The delivery order supports federal healthcare agencies,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $3,317.80 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 26, 2025. This contract award carries no set-aside designation and includes economic price adjustment provisions. The award supports the federal government's medical supply chain operations, which fall under the...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F094GDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $8,427 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 3, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment pricing and involves no set-aside designation, indicating open market competition. The award covers SIMPLIFY spinal surgery products and related medical devices to be delivered to the San Diego, CA area. This delivery order is issued under Nuvasive's broader procurement relationship with the DLA Medical Supply Chain, which serves as the primary funding mechanism for specialized orthopedic and neurosurgical technologies supporting Department of Defense and Department of Veterans Affairs healthcare facilities. This award reflects Nuvasive's established role as a critical supplier of advanced spinal implants, bone graft materials, surgical instruments, and related biologics to federal healthcare agencies. The short performance window of fewer than four days indicates the urgent medical supply requirements typical of military healthcare systems. Nuvasive operates under a strategic $8 million Blanket Purchase Agreement with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity contract effective through March 2027, which facilitates streamlined procurement and rapid ordering of its comprehensive portfolio of spinal medical technologies across Department of Defense and Veterans Health Administration networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 10/31/25 |